Norman Payson - 21 May 2026 Form 4 Insider Report for Progyny, Inc. (PGNY)

Reporting relationship: Director
Issuer ticker: PGNY
Reported as of: 21 May 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 26 May 2026, 16:21:52 UTC
Prior SEC filing: 18 Nov 2025
Source filing: View source filing
Reporting owner signature: /s/ Mark Livingston, Attorney-in-Fact

Key filing fact

Norman Payson filed Form 4 for Progyny, Inc. (PGNY) on 26 May 2026.

Key facts

This page summarizes Norman Payson's Form 4 filing for Progyny, Inc. (PGNY).
3 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 26 May 2026, 16:21.

Change

Previous filing in this sequence was filed on 18 Nov 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0000898544 Primary reporting owner

Payson Norman

Relationship: Director
Address: C/O PROGYNY, INC., 1359 BROADWAY, 2ND FLOOR, NEW YORK
Signature: /s/ Mark Livingston, Attorney-in-Fact
Signature date: 26 May 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

PGNY transaction

Common Stock

Award

Transaction value
Shares: +5,660
Change %: +85%
Price: $0.000000^*
Shares after: 12,349
Date: 21 May 2026
Ownership: Direct
Footnotes: F1

PGNY holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 331,363
Date: 21 May 2026
Ownership: See footnote
Footnotes: F2

PGNY holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 122,493
Date: 21 May 2026
Ownership: See footnote
Footnotes: F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

PGNY transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value
Shares: +3,203
Change %
Price: $12.49^*
Shares after: 3,203
Date: 21 May 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 3,203
Exercise price: $24.69
Footnotes: F4

PGNY transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value
Shares: +27,119
Change %
Price: $0.000000^*
Shares after: 27,119
Date: 21 May 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 27,119
Exercise price: $24.69
Footnotes: F5

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 5 footnotes

Footnote F1

Represents the number of shares of Issuer common stock underlying restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Issuer common stock. The RSUs will vest on the earlier of (i) May 21, 2027 or (ii) the calendar day immediately preceding the date of the Issuer's first annual meeting of stockholders following the grant date, subject to the Reporting Person's continued service on such date.

Footnote F2

The reportable securities are directly held by Norman C. Payson and Melinda B. Payson, Trustees of The Norman C. and Melinda B. Payson Revocable Trust.

Footnote F3

The reportable securities are directly held by EVO Eagle, LLC. The Reporting Person shares voting and dispositive power over the securities.

Footnote F4

The option was issued to the Reporting Person in lieu of an annual cash retainer of $39,990 for board and committee service. The shares subject to the option will vest on the earlier of (i) May 21, 2027 or (ii) the calendar day immediately preceding the date of the Issuer's first annual meeting of stockholders following the grant date, subject to the Reporting Person's continued service on such date.

Footnote F5

The shares subject to the option will vest on the earlier of (i) May 21, 2027 or (ii) the calendar day immediately preceding the date of the Issuer's first annual meeting of stockholders following the grant date, subject to the Reporting Person's continued service on such date.